Use of riluzole for the treatment of multiple sclerosis

Details Use of riluzole for the treatment of multiple sclerosis Use of riluzole for the treatment of multiple sclerosis

2005-03-29

2005-03-29

Spivack, Phyllis G. (Department: 1614)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

Reexamination Certificate

active

06872739

ABSTRACT:
Methods for the treatment of multiple sclerosis are disclosed comprising administering 6-(triflouromethoxy)-2-benzothiazolamine or a salt thereof.

REFERENCES:
patent: 4826860 (1989-05-01), Johnson et al.
patent: 5236940 (1993-08-01), Audiau et al.
patent: 6245791 (2001-06-01), Bohme et al.
patent: 6387936 (2002-05-01), Blanchard-Bregeon et al.
patent: WO 93 17683 (1993-09-01), None
patent: 9841882 (1998-09-01), None
patent: WO 9951097 (1999-01-01), None
patent: WO 9947692 (1999-09-01), None
patent: WO 0054773 (2000-09-01), None
patent: WO 0195907 (2001-12-01), None
Schluep et al., Medecine et Hygiene, 55/2145 (33-35) (1997), (abstract).*
G. McCready (ED.): “Rilutek might be tried for MS” MS Pathfinder, Jun. 1998, XP002122163.
N.F. Kalkes: “A pilot study of riluzole in primary progressive multiple sclerosis; effect on spinal cord atrophy on MRI” 9TH Meeting of the European Neurological Society, Poster P419, Jun. 6, 1999, XP002122164.
B. Stankoff: “Neuroprotection and Central Nervous System myelination: New prospects for multiple sclerosis?” Neurology, vol. 52, No. 6, (1999).
Kalkers et al., Multiple Sclerosis (2002) 8: 532-533.

Affiliated with

Also associated with

Rating

Use of riluzole for the treatment of multiple sclerosis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of riluzole for the treatment of multiple sclerosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of riluzole for the treatment of multiple sclerosis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3397285